Found: 7
Select item for more details and to access through your institution.
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
- Published in:
- Clinical & Experimental Metastasis, 2002, v. 19, n. 6, p. 519, doi. 10.1023/A:1020321210623
- By:
- Publication type:
- Article
Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis.
- Published in:
- Journal of Clinical Investigation, 2004, v. 114, n. 7, p. 898, doi. 10.1172/JCI200421152
- By:
- Publication type:
- Article
Combination Therapy of Interleukin-2 and Sorafenib Improves Survival Benefits and Prevents Spontaneous Pulmonary Metastasis in Murine Renal Cell Carcinoma Models.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 6, p. 503, doi. 10.1093/jjco/hyp200
- By:
- Publication type:
- Article
Antitumor Efficacy of Recombinant Human Interleukin-2 Combined with Sorafenib Against Mouse Renal Cell Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 5, p. 303, doi. 10.1093/jjco/hyp021
- By:
- Publication type:
- Article
S-222611, an oral reversible tyrosine kinase inhibitor of EGFR and HER2. A representative histological image of the colon treated with S-222611 (25 mg/kg).
- Published in:
- 2014
- By:
- Publication type:
- Other
Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2.
- Published in:
- Cancer Science, 2014, v. 105, n. 8, p. 1040, doi. 10.1111/cas.12449
- By:
- Publication type:
- Article
Preclinical in vivo Antitumor Efficacy of Nedaplatin with Gemcitabine against Human Lung Cancer.
- Published in:
- Cancer Science, 2001, v. 92, n. 1, p. 51, doi. 10.1111/j.1349-7006.2001.tb01047.x
- By:
- Publication type:
- Article